EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte Studie

Enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula oxygen therapy: A randomized crossover trial

Yorihide Yanagita iD, Shinichi Arizono iD, Koshi Yokomura, Kumiko Ito, Hikaru Machiguchi iD, Yuichi Tawara, Norimasa Katagiri, Yuki Iida, Eiji Nakatani, Takako Tanaka, Ryo Kozu

Respirology · 2024-06 · 29 (6) · 497-504

DOI: 10.1111/resp.14684 ↗

At a glance

Randomisierte kontrollierte Studie in Respirology, published online on 2024-02-22. Written by Yorihide Yanagita and 10 co-authors. Institution: Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Major MEDLINE topics: Cross-Over Studies, Lung Diseases, Interstitial, Oxygen Inhalation Therapy, Exercise Tolerance. Cited 12 times so far (Crossref); 28 references. Funded by: Japan Society for the Promotion of Science (JSPS).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Objective Interstitial lung disease (ILD) is characterized by dyspnoea on exertion and exercise‐induced hypoxaemia. High‐flow nasal cannula (HFNC) therapy reduces the respiratory workload through higher gas flow and oxygen supplementation, which may affect exercise tolerance. This study aimed to examine the effects of oxygen and gas flow rates through HFNC therapy on exercise tolerance in ILD patients.

Methods

We conducted three‐treatment crossover study. All ILD patients performed the exercises on room air (ROOM AIR setting: flow, 0 L/min; fraction of inspired oxygen [FiO 2 ], 0.21), HFNC (FLOW setting: flow 40 L/min, FiO 2 0.21), and HFNC with oxygen supplementation (FLOW + OXYGEN setting: flow 40 L/min, FiO 2 0.6). The primary endpoint was the endurance time, measured using constant‐load cycle ergometry exercise testing at a peak work rate of 80%.

Results

Twenty‐five participants (10 men, 71.2 ± 6.7 years) were enrolled. The increase in exercise duration between the ROOM AIR and FLOW was 46.3 s (95% CI, −6.1 to 98.7; p = 0.083), and the FLOW and FLOW + OXYGEN was 91.5 s (39.1–143.9; p < 0.001). The percutaneous oxygen saturation (SpO 2 ) at rest was significantly higher with the FLOW + OXYGEN setting than with the ROOM AIR and FLOW settings, and the difference persisted during exercise. At equivalent time points during exercise, the SpO 2 with the FLOW setting was significantly higher than that with the ROOM AIR setting.

Conclusion

Oxygen supplementation in HFNC therapy improved exercise tolerance and SpO 2 . We found that gas flow alone did not improve exercise tolerance, but improved SpO 2 during exercise. image

Subjects

MeSH terms (MEDLINE)

Cross-Over StudiesLung Diseases, InterstitialOxygen Inhalation TherapyExercise ToleranceCannulaHumansMaleFemaleAgedExercise TestMiddle AgedTreatment OutcomeOxygen

Author keywords

endurance timegas flowhigh‐flow nasal cannulainterstitial lung diseaseoxygen

Substances

Oxygen

Authors and institutions

  • Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Department of Physical Therapy, School of Rehabilitation Sciences, Seirei Christopher University, Hamamatsu, Japan.
  • Division of Respiratory Medicine, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Department of Rehabilitation, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Department of Rehabilitation, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
  • Department of Rehabilitation Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

ORCID profiles: Yorihide Yanagita, Shinichi Arizono, Hikaru Machiguchi

Funding

  • Japan Society for the Promotion of Science (JSPS)

Cite

APA

Yanagita, Y., Arizono, S., Yokomura, K., Ito, K., Machiguchi, H., Tawara, Y., Katagiri, N., Iida, Y., Nakatani, E., Tanaka, T., & Kozu, R. (2024). Enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula oxygen therapy: A randomized crossover trial. Respirology, 29(6), 497-504. https://doi.org/10.1111/resp.14684

Vancouver

Yanagita Y, Arizono S, Yokomura K, Ito K, Machiguchi H, Tawara Y, et al. Enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula oxygen therapy: A randomized crossover trial. Respirology. 2024;29(6):497-504. doi:10.1111/resp.14684

BibTeX
@article{Yanagita2024,
  author = {Yanagita, Yorihide and Arizono, Shinichi and Yokomura, Koshi and Ito, Kumiko and Machiguchi, Hikaru and Tawara, Yuichi and Katagiri, Norimasa and Iida, Yuki and Nakatani, Eiji and Tanaka, Takako and Kozu, Ryo},
  title = {Enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula oxygen therapy: A randomized crossover trial},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {6},
  pages = {497--504},
  doi = {10.1111/resp.14684}
}
Start for free →